<DOC>
	<DOCNO>NCT01097629</DOCNO>
	<brief_summary>This multicenter study test hypothesis suvorexant ( MK-4305 ) superior placebo improve insomnia measure change baseline : subjective total sleep time time sleep onset , wake time persistent sleep onset , latency onset persistent sleep .</brief_summary>
	<brief_title>Safety Efficacy Study Suvorexant Participants With Primary Insomnia - Study B ( MK-4305-029 )</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Suvorexant</mesh_term>
	<criteria>Must ≥18 yr old day signing inform consent Diagnosed Primary Insomnia Good physical mental health Participant ≥65 yr old score least 25 Mini Mental State Examination A female participant reproductive potential negative serum pregnancy test agree use contraception Reports difficulty initiate maintain sleep 4 week prior Visit 1 ( accordingly specific protocol criterion ) Reports spend 6.5 9 hour nightly bed least 3 7 night prior Visit 1 Regular bedtime 9 pm1 Willing refrain napping study Able read , understand complete questionnaire diary Willing limit alcohol , caffeine , nicotine consumption study For portion participant : Must willing stay overnight sleep laboratory must willing stay bed least 8 hour night sleep laboratory Female participant pregnant and/or breastfeed Prestudy visit , expect conceive study History diagnosis another sleep disorder Difficulty sleep due medical condition History neurological disorder History bipolar disorder , psychotic disorder , posttraumatic stress disorder , current psychiatric disorder require prohibit medication Ongoing depression History substance abuse dependence History current evidence clinically significant cardiovascular disorder clinically significant electrocardiogram ( ECG ) Prestudy Visit Taking certain prohibit medication Consumption equivalent &gt; 15 cigarette day History malignancy ≤5 year prior sign inform consent , except adequately treat basal cell squamous cell skin cancer situ cervical cancer Participant consider morbidly obese Previously randomize another investigational study suvorexant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>